The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 15 August 2006, www.theannals.com, DOI 10.1345/aph.1G525.
The Annals of Pharmacotherapy: Vol. 40, No. 9, pp. 1594-1601. DOI 10.1345/aph.1G525
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, D.
Right arrow Articles by Rieder, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, D.
Right arrow Articles by Rieder, M. J

HIV/AIDS

Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection

Daren Lin, BA

Medical Student, Department of Pediatrics, University of Western Ontario, London, Ontario, Canada

M Jane Tucker, PhD

Adjunct Professor, Section of Pediatric Clinical Pharmacology, Department of Pediatrics, University of Western Ontario

Michael J Rieder, MD PhD FRCPC

Professor, Departments of Pediatrics, Medicine, and Physiology and Pharmacology, Robarts Research Institute, University of Western Ontario

Reprints: Dr. Rieder, Children's Hospital of Western Ontario, 800 Commissioners Rd. E., London, ON N6C 2V5, Canada, fax 519/685-8156; mrieder{at}uwo.ca

OBJECTIVE: To review the incidence, signs, symptoms, and mechanisms of adverse drug reactions (ADRs) to sulfonamides, anticonvulsants, and antimycobacterial medications among people with HIV.

DATA SOURCES: Searches of MEDLINE/PubMed (1980-November 2005) and National Library of Medicine Meeting Abstracts (1989-November 2005), as well as hand searches of journals and abstracts, were conducted to identify primary literature. Reference lists were reviewed to identify additional relevant reports.

STUDY SELECTION AND DATA EXTRACTION: Relevant articles and abstracts, particularly of in vitro experiments and clinical studies, were compiled and reviewed.

DATA SYNTHESIS: ADRs, especially in HIV-infected patients, are a cause for concern. Sulfonamides, anticonvulsants, and antimycobacterial drugs are commonly used to prevent and treat complications of HIV, including seizures and opportunistic infections. Patients with HIV have a much greater rate of ADRs to these drug classes, including severe and life-threatening hypersensitivity reactions. Several mechanisms of these ADRs have been postulated. Sulfamethoxazole and anticonvulsant hypersensitivity may involve the increased formation and decreased detoxification of reactive metabolites. The mechanisms for the marked increase in hypersensitivity ADRs to antimycobacterial drugs may be related to an altered immune profile in patients infected with both tuberculosis and HIV.

CONCLUSIONS: ADRs to antimicrobial and anticonvulsant therapy cause markedly increased morbidity and mortality in HIV-positive patients. Further research involving the interaction between HIV and the increased ADRs to these drugs is required.

Key Words: adverse effects, anticonvulsants, HIV, sulfonamides, thiacetazone

Published Online, August 15, 2006. www.theannals.com, DOI 10.1345/aph.1G525





homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.